Dissociation of cerebrospinal fluid amyloid- and tau levels in patients with prolonged posttraumatic disorders of consciousness

被引:9
|
作者
Bagnato, Sergio [1 ,2 ]
Andriolo, Maria [3 ]
Boccagni, Cristina [1 ,2 ]
Sant'Angelo, Antonino [1 ,2 ]
D'Ippolito, Maria Enza [3 ]
Galardi, Giuseppe [1 ,2 ]
机构
[1] Giuseppe Giglio Fdn, Unit Neurophysiol, Rehabil Dept, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy
[2] Giuseppe Giglio Fdn, Unit Severe Acquired Brain Injuries, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy
[3] Giuseppe Giglio Fdn, Clin Pathol & Microbiol Lab, Cefalu, Italy
关键词
Amyloid beta; traumatic brain injury; total tau; phosphorylated tau; vegetative state; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; DEMENTIA; RISK; BIOMARKERS; INFLAMMATION; CONCORDANCE; POPULATION; PATHOLOGY;
D O I
10.1080/02699052.2018.1479042
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Traumatic brain injury (TBI) is a major risk factor for Alzheimer's disease (AD). Although the mechanisms that lead to AD after a TBI are unclear, we hypothesize that changes in amyloid- (A) metabolism and abnormal tau phosphorylation are reasonable candidates.Objective: To investigate A and tau dynamics in the chronic phase of TBI.Methods: We evaluated A(1-42), total tau (t-tau), and phosphorylated tau (p-tau) levels in the cerebrospinal fluid (CSF) of 15 patients who developed a prolonged disorder of consciousness after a severe TBI (mean time from TBI 271.6176.5days).Results: Reduced A(1-42) levels (median 258pg/ml, range 90-833.6) were observed in 14/15 patients (93.3%) with severe post-TBI disorders of consciousness. These CSF analysis data did not correlate with time since TBI or with the patients' level of consciousness as determined by the Coma Recovery Scale Revised. Normal t-tau levels (median 95.2 pg/ml, range 52-256.9) were found in all patients. Normal p-tau levels (median 22.2pg/ml, range 14-72) were observed in 14/15 patients, with just a single patient having a slightly increased p-tau level.Conclusion: The present findings show that A and tau are differently affected in the chronic phase of severe TBI.
引用
收藏
页码:1056 / 1060
页数:5
相关论文
共 50 条
  • [1] Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia
    Chen, Dong-Wan
    Wang, Jun
    Zhang, Li-Li
    Wang, Yan-Jiang
    Gao, Chang-Yue
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (02) : 645 - 651
  • [2] Prolonged Cerebrospinal Fluid Neurofilament Light Chain Increase in Patients with Post-Traumatic Disorders of Consciousness
    Bagnato, Sergio
    Grimaldi, Luigi M. E.
    Di Raimondo, Giorgio
    Sant'Angelo, Antonino
    Boccagni, Cristina
    Virgilio, Vittorio
    Andriolo, Maria
    JOURNAL OF NEUROTRAUMA, 2017, 34 (16) : 2475 - 2479
  • [3] Age-associated changes of cerebrospinal fluid amyloid-β and tau in cynomolgus monkeys
    Yue, Feng
    Lu, Chunling
    Ai, Yi
    Chan, Piu
    Zhang, Zhiming
    NEUROBIOLOGY OF AGING, 2014, 35 (07) : 1656 - 1659
  • [4] Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia
    Skillback, Tobias
    Farahmand, Bahman Y.
    Rosen, Christoffer
    Mattsson, Niklas
    Nagga, Katarina
    Kilander, Lena
    Religa, Dorota
    Wimo, Anders
    Winblad, Bengt
    Schott, Jonathan M.
    Blennow, Kaj
    Eriksdotter, Maria
    Zetterberg, Henrik
    BRAIN, 2015, 138 : 2716 - 2731
  • [5] Plasma levels of Interleukin 18 but not amyloid-β or Tau are elevated in female depressive patients
    Liu, Fa-rong
    Yang, Lu-yin
    Zheng, Hui-fei
    Zhou, Yunqiang
    Chen, Bin-bin
    Xu, Huaxi
    Zhang, Yun-wu
    Shen, Dong-yan
    COMPREHENSIVE PSYCHIATRY, 2020, 97
  • [6] Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?
    Travassos, Maria
    Santana, Isabel
    Baldeiras, Ines
    Tsolaki, Magda
    Gkatzima, Olymbia
    Genc, Sermin
    Yener, Gorsev G.
    Simonsen, Anja
    Hasselbalch, Steen G.
    Kapaki, Elisabeth
    Bourbouli, Mara
    Cunha, Rodrigo A.
    Agostinho, Paula
    Blennow, Kaj
    Zetterberg, Henrik
    Mendes, Vera M.
    Manadas, Bruno
    de Mendonca, Alexandre
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (04) : 1069 - 1078
  • [7] Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus
    Kawamura, Kaito
    Miyajima, Masakazu
    Nakajima, Madoka
    Kanai, Mitsuyasu
    Motoi, Yumiko
    Nojiri, Shuko
    Akiba, Chihiro
    Ogino, Ikuko
    Xu, Hanbing
    Kamohara, Chihiro
    Yamada, Shinya
    Karagiozov, Kostadin
    Ikeuchi, Takeshi
    Kondo, Akihide
    Arai, Hajime
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 83 (01) : 179 - 190
  • [8] Serum and Cerebrospinal Fluid Uric Acid Levels in Lewy Body Disorders: Associations with Disease Occurrence and Amyloid-β Pathway
    Maetzler, Walter
    Stapf, Anne Kathrin
    Schulte, Claudia
    Hauser, Ann-Kathrin
    Lerche, Stefanie
    Wurster, Isabel
    Schleicher, Erwin
    Melms, Arthur
    Berg, Daniela
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 27 (01) : 119 - 126
  • [9] Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
    Voyle, Nicola
    Patel, Hamel
    Folarin, Amos
    Newhouse, Stephen
    Johnston, Caroline
    Visser, Pieter Jelle
    Dobson, Richard J. B.
    Kiddle, Steven J.
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (04) : 1417 - 1427
  • [10] Plasma Levels of Amyloid-β Peptides and Tau Protein in Mexican Patients with Alzheimer's Disease
    Castillo-Mendieta, Tzayaka
    Arana-Lechuga, Yoaly
    Campos-Pena, Victoria
    Luisa Sosa, Ana
    Orozco-Suarez, Sandra
    Pinto-Almazan, Rodolfo
    Segura-Uribe, Julia
    Rodriguez-Sanchez de Tagle, Aldo Javier
    Ruiz-Sanchez, Elizabeth
    Guerra-Araiza, Christian
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 82 : S271 - S281